Slovenia starts using antibody treatment for Covid-19 patients

Ljubljana, 24 August - Slovenia has started using monoclonal antibody treatment for some patients with Covid-19, having received a shipment of 1,000 doses of the drug, which has been developed by the US biotech company Regeneron, as part of an EU contract.